pSL1419
(Plasmid
#219778)
-
PurposepDEF-TurboID-GFPmut2, negative control for cytosolic expression
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 219778 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepDEF
-
Vector typePlasmodium, rodent malaria parasites
-
Selectable markersHuman DHFR
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameTurboID/GFPmut2
-
SpeciesSynthetic
-
Insert Size (bp)1709
- Promoter PbEF1alpha promoter
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site KpnI (not destroyed)
- 3′ cloning site BamHI (not destroyed)
- 5′ sequencing primer n/a (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
This plasmid can be integrated into the p230p locus for Plasmodium yoelii (and likely also Plasmodium berghei). The TurboID/GFPmut2 fusion protein is expressed via a PbEF1alpha promoter to create an unfused control protein that is expressed in a cytosolic diffuse manner. This is used as a negative control for TurboID proximity proteomics for proteins that are found in the cytosol.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pSL1419 was a gift from Scott Lindner (Addgene plasmid # 219778 ; http://n2t.net/addgene:219778 ; RRID:Addgene_219778) -
For your References section:
Global Release of Translational Repression Across Plasmodium's Host-to-Vector Transmission Event. Rios KT, McGee JP, Sebastian A, Moritz RL, Feric M, Absalon S, Swearingen KE, Lindner SE. bioRxiv [Preprint]. 2024 Mar 16:2024.02.01.577866. doi: 10.1101/2024.02.01.577866. 10.1101/2024.02.01.577866 PubMed 38352447